Martinowitz U, Schulman S, Horoszowski H, Heim M
National Hemophilia Center, The Chaim Sheba Medical Center, Tel Hashomer, Israel.
Clin Orthop Relat Res. 1996 Jul(328):65-75. doi: 10.1097/00003086-199607000-00013.
Fibrin sealants have until now been used to a very limited extent in patients with a bleeding diathesis. The authors have accumulated experience from 8 minor and 40 major surgical procedures, plus 10 circumcisions and 118 tooth extractions in 106 patients suffering from hemophilia A, B, or von Willebrand's disease. Most of the patients had the severe form of the disease. The authors were able to show a reduction of blood loss and of requirements for replacement therapy with factor concentrates. The literature on the application of fibrin sealants in this group of patients, which mainly deals with dental procedures, is reviewed and compared with data from the current study. The composition of the glue is of major significance and is discussed in detail.
迄今为止,纤维蛋白封闭剂在有出血素质的患者中的应用非常有限。作者积累了106例患有甲型、乙型血友病或血管性血友病患者的经验,这些患者接受了8例小手术、40例大手术、10例包皮环切术和118例拔牙术。大多数患者患有严重形式的疾病。作者能够证明出血量减少以及浓缩因子替代治疗需求的减少。本文回顾了关于纤维蛋白封闭剂在这类患者(主要涉及牙科手术)中的应用文献,并与当前研究的数据进行了比较。详细讨论了胶水的成分,其具有重要意义。